Recommendations for diagnosis and treatment of primary biliary cholangitis in China (2021)
10.3760/cma.j.cn112138-20210520-00360
- VernacularTitle:原发性胆汁性胆管炎诊疗规范（2021）
- Author:
Fengchun ZHANG
1
;
Li WANG
;
Zongwen SHUAI
;
Zhenbiao WU
;
Wen ZHANG
;
Zhuoli ZHANG
;
Jin LIN
;
Yan ZHAO
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 疑难重症及罕见病国家重点实验室 风湿免疫病学教育部重点实验室 100730
- Keywords:
Primary biliary cholangitis;
Diagnosis;
Treatment;
Prognosis
- From:
Chinese Journal of Internal Medicine
2021;60(8):709-715
- CountryChina
- Language:Chinese
-
Abstract:
Primary biliary cholangitis is a chronic autoimmune cholestatic disease with a progressive course. This disease is not rare in China, but standardized diagnosis and treatment for primary biliary cholangitis are insufficient. Based on the evidence and guidelines from China and other countries, Rheumatology Branch of Chinese Medical Association developed the recommendations of diagnosis and treatment for primary biliary cholangitis in China. The aim is to help clinicians recognize clinical characters, therapeutic selection and prognosis judgement of primary biliary cholangitis, which will contribute to make diagnosis in time, to select treatment properly and to manage follow-up scientifically.
